6.
Cannon B, Nedergaard J
. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004; 84(1):277-359.
DOI: 10.1152/physrev.00015.2003.
View
7.
Schwartz M, Woods S, Porte Jr D, Seeley R, Baskin D
. Central nervous system control of food intake. Nature. 2000; 404(6778):661-71.
DOI: 10.1038/35007534.
View
8.
Sonnenberg-Riethmacher E, Wustefeld T, Miehe M, Trautwein C, Riethmacher D
. Maid (GCIP) is involved in cell cycle control of hepatocytes. Hepatology. 2007; 45(2):404-11.
DOI: 10.1002/hep.21461.
View
9.
Enomoto H, Ueno Y, Hiasa Y, Nishikawa H, Hige S, Takikawa Y
. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2019; 55(3):353-362.
PMC: 7026312.
DOI: 10.1007/s00535-019-01645-y.
View
10.
Morgan D, McDaniel L, Yin T, Khan M, Jiang J, Acevedo M
. Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus. Diabetes. 2015; 64(6):1976-87.
PMC: 4439564.
DOI: 10.2337/db14-1257.
View
11.
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R
. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9.
DOI: 10.1007/BF00280883.
View
12.
Martelli D, Brooks V
. Leptin Increases: Physiological Roles in the Control of Sympathetic Nerve Activity, Energy Balance, and the Hypothalamic-Pituitary-Thyroid Axis. Int J Mol Sci. 2023; 24(3).
PMC: 9917048.
DOI: 10.3390/ijms24032684.
View
13.
Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante Jr A
. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808.
PMC: 296995.
DOI: 10.1172/JCI19246.
View
14.
Perazzo H, Dufour J
. The therapeutic landscape of non-alcoholic steatohepatitis. Liver Int. 2016; 37(5):634-647.
DOI: 10.1111/liv.13270.
View
15.
Balthasar N, Dalgaard L, Lee C, Yu J, Funahashi H, Williams T
. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell. 2005; 123(3):493-505.
DOI: 10.1016/j.cell.2005.08.035.
View
16.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M
. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84.
DOI: 10.1002/hep.28431.
View
17.
Rinella M, Lazarus J, Ratziu V, Francque S, Sanyal A, Kanwal F
. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2023; 29(1):101133.
DOI: 10.1016/j.aohep.2023.101133.
View
18.
Toda G, Soeda K, Okazaki Y, Kobayashi N, Masuda Y, Arakawa N
. Insulin- and Lipopolysaccharide-Mediated Signaling in Adipose Tissue Macrophages Regulates Postprandial Glycemia through Akt-mTOR Activation. Mol Cell. 2020; 79(1):43-53.e4.
DOI: 10.1016/j.molcel.2020.04.033.
View
19.
Terai S, Aoki H, Ashida K, Thorgeirsson S
. Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression. Hepatology. 2000; 32(2):357-66.
DOI: 10.1053/jhep.2000.9092.
View
20.
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti G
. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci. 2019; 20(9).
PMC: 6539070.
DOI: 10.3390/ijms20092358.
View